drugset / Trial / NCT05057546

Ovarian Hormone Regulation of Central and Cerebrovascular Hemodynamics (NoMEN Study)

NCT05057546

Phase 4 Active not recruiting 55 enrolled University of Colorado, Denver
NaSingle-groupOpen-labelBasic science

Summary

This study will evaluate changes in blood vessels around the heart (e.g., aorta and carotid arteries) and in the brain with the loss of female sex hormones (e.g., estrogen) during the menopause transition. The menopause transition is associated with declines in blood vessel function and increased risk for cardiovascular disease and Alzheimer's disease. Increasing evidence supports an early role for declines in blood vessel function and future development of Alzheimer's disease in aging men and women. This study will learn about the effects of changes in female sex hormones, such as estrogen, during the menopause transition on blood vessel around the heart and in the brain in women.

Timeline

Start
2021-11-22
Primary completion
2024-09-18
Completion
2025-07-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Degarelix Other / unclassified 80 mg Subcutaneous

Indications

No indication recorded.